ID

34153

Description

MIBG Scintigraphy and Strain Echocardiography in the Detection of Subclinical Cardiovascular Effects One Year After (Neo)Adjuvant Breast Cancer Treatment With Docetaxel, Doxorubicin and Cyclophosphamide (TAC): a Pilot Study; ODM derived from: https://clinicaltrials.gov/show/NCT01246856

Link

https://clinicaltrials.gov/show/NCT01246856

Keywords

  1. 1/14/19 1/14/19 -
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 14, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Cancer NCT01246856

Eligibility Breast Cancer NCT01246856

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
female patients with breast cancer, ≥ 18 years old at the time of breast cancer diagnosis
Description

ID.1

Data type

boolean

(neo)adjuvant treatment with docetaxel, doxorubicin and cyclophosphamide (tac) completed one year before inclusion
Description

ID.2

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
evidence of breast cancer recurrence or metastatic disease
Description

ID.3

Data type

boolean

evidence of heart disease at the time of breast cancer diagnosis
Description

ID.4

Data type

boolean

evidence of renal failure at the time of cardiac evaluation
Description

ID.5

Data type

boolean

pregnant or lactating
Description

ID.6

Data type

boolean

participation in a research protocol with ionizing radiation within one year before inclusion.
Description

ID.7

Data type

boolean

evidence of diabetes mellitus or parkinson's disease
Description

ID.8

Data type

boolean

evidence of an mibg-accumulating tumor (pheochromocytoma, paraganglioma, chemodectoma, ganglioneuroma, neuroblastoma, carcinoid, medullary thyroid cancer, neurofibromatosis, retinoblastoma, esthesioneuroma, schwannoma, merkelcel-tumor, pancreatic islet cell tumors, small cell lung carcinoma, melanoma
Description

ID.9

Data type

boolean

Similar models

Eligibility Breast Cancer NCT01246856

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
female patients with breast cancer, ≥ 18 years old at the time of breast cancer diagnosis
boolean
ID.2
Item
(neo)adjuvant treatment with docetaxel, doxorubicin and cyclophosphamide (tac) completed one year before inclusion
boolean
Item Group
C0680251 (UMLS CUI)
ID.3
Item
evidence of breast cancer recurrence or metastatic disease
boolean
ID.4
Item
evidence of heart disease at the time of breast cancer diagnosis
boolean
ID.5
Item
evidence of renal failure at the time of cardiac evaluation
boolean
ID.6
Item
pregnant or lactating
boolean
ID.7
Item
participation in a research protocol with ionizing radiation within one year before inclusion.
boolean
ID.8
Item
evidence of diabetes mellitus or parkinson's disease
boolean
ID.9
Item
evidence of an mibg-accumulating tumor (pheochromocytoma, paraganglioma, chemodectoma, ganglioneuroma, neuroblastoma, carcinoid, medullary thyroid cancer, neurofibromatosis, retinoblastoma, esthesioneuroma, schwannoma, merkelcel-tumor, pancreatic islet cell tumors, small cell lung carcinoma, melanoma
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial